Solid-organ transplant recipients treated with drotrecogin alfa (activated) for severe sepsis
作者:
Sanjay Kulkarni,
Edward Naureckas,
David Cronin,
期刊:
Transplantation
(OVID Available online 2003)
卷期:
Volume 75,
issue 6
页码: 899-901
ISSN:0041-1337
年代: 2003
出版商: OVID
数据来源: OVID
摘要:
Severe sepsis in immunosuppressed recipients of solid-organ transplants is associated with a high mortality. Conventional management of sepsis in this patient population has not specifically attempted to treat the underlying inflammatory or procoagulant responses that contribute to the development of multisystem organ failure. Drotrecogin alfa (activated, human activated protein C) has been shown to be a safe and effective adjuvant in the treatment of severe sepsis; however, experience in recipients of solid-organ transplants has not been addressed. The treatments and outcomes of three solid-organ transplant recipients (liver, kidney, and kidney-pancreas) who experienced episodes of severe sepsis are presented and demonstrate initial success with the use of drotrecogin alfa (activated).
点击下载:
PDF
(300KB)
返 回